Adial Pharmaceuticals (NASDAQ:ADIL) Posts Quarterly Earnings Results, Misses Estimates By $0.20 EPS
Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.20), Zacks reports. Adial Pharmaceuticals Price Performance Shares of ADIL stock remained flat at $0.97 on Thursday. 167,506 shares of the stock traded […]
More Stories
UN chief strongly condemns Mali terrorist attack
UN Secretary-General António Guterres has called for accountability following a “despicable” terrorist attack in Mali this week, his Spokesperson said...
Whole generation of children ‘lost’ amid ongoing Gaza war, UNICEF warns
Last October’s terror attacks by Hamas and other Palestinian armed groups on Israeli communities marked a devastating day for children,...
Security Council: Middle East envoy warns against escalation, highlights continued Israeli settlement activity
The UN envoy supporting peace efforts between Israelis and Palestinians voiced grave concern over the growing risk of widescale regional...
Blackstone Inc. (NYSE:BX) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Blackstone Inc. (NYSE:BX – Get Free Report) have been given an average recommendation of “Hold” by the nineteen...
Reserve Bank Urged to Adapt After US Fed’s Aggressive Interest Rate Reduction
By Naziya Alvi Rahman The U.S. Federal Reserve announced on Sept. 18 that it would cut interest rates by half...
Coterra Energy Inc. (NYSE:CTRA) Short Interest Update
Coterra Energy Inc. (NYSE:CTRA – Get Free Report) was the target of a significant decrease in short interest in the...